                </a></li></ul></div><p><strong>Figure 1.  <span>A) Summary of RB mutants.</span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>The amino acid numbering is that of the human retinoblastoma protein.</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p2" name="article1.body1.sec3.sec1.fig1.caption1.p2"></a><p>Two shaded boxes represent the A and B domains; I, the insert region; N, the region N-terminal to the A domain; C, the region C-terminal to the B domain.</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p3" name="article1.body1.sec3.sec1.fig1.caption1.p3"></a><p>B) GST pull-down assay.</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p4" name="article1.body1.sec3.sec1.fig1.caption1.p4"></a><p>The RB-deficient MDA-MB468 cells were infected with recombinant adenovirus encoding GFP, RB, RB-K, RB-N or RB-KN, whole cell lysates were incubated with purified GST-E2F1 or GST-E7 fusion protein immobilized on glutathione-Sepharose.</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p5" name="article1.body1.sec3.sec1.fig1.caption1.p5"></a><p>The bound fractions were solubilized, fractionated by SDS-PAGE and reacted with an affinity-purified anti-RB.</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p6" name="article1.body1.sec3.sec1.fig1.caption1.p6"></a><p>C) Reciprocal GST pull-down assay.</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p7" name="article1.body1.sec3.sec1.fig1.caption1.p7"></a><p>Lysates from SAOS-2-tet-E2F1 cells <a href="#pone.0000082-Phillips1">[21]</a> were immunoblotted with anti-E2F1 to demonstrate the induced expression of E2F1 protein (upper panel).</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p8" name="article1.body1.sec3.sec1.fig1.caption1.p8"></a><p>Lysates from induced and non-induced cells were incubated with GST-RB or GST-RB-K fusion proteins immobilized on glutathione-Sepharose, and the bound fraction analyzed by immunoblotting with anti-E2F1 (lower panel).</p>
